Citations

Mayo Clinic

Showing 10 of 108551 citations.

Associations between attending physician workload, teaching effectiveness, and patient safety
Wingo, Majken T. , Halvorsen, Andrew J. , Beckman, Thomas J. , Johnson, Matthew G. , Reed, Darcy A.

Journal of Hospital Medicine | January 7, 2016 | Volume: 11 | Issue: 3 | Pages: 169-173

10.1002/jhm.2540 | PMID 26741703 Get It

BACKGROUNDPrior studies suggest that high workload among attending physicians may be associated with reduced teaching effectiveness and poor patient outcomes, but these relationships have not been investigated using objective measures of workload and safety.OBJECTIVETo examine associations between attending workload, teaching effectiveness, and patient safety, hypothesizing that higher workload would be associated with lower teaching effectiveness and negative patient outcomes.DESIGN, SETTING, AND PARTICIPANTSWe conducted a retrospective study of 69,386 teaching evaluation items submitted by 543 internal medicine residents for 107 attending physicians who supervised inpatient teaching services from July 2, 2005 to July 1, 2011.MEASUREMENTSAttending workload measures included hospital service census, patient length of stay, daily admissions, daily discharges, and concurrent outpatient duties. Teaching effectiveness was measured using residents' evaluations of attendings. Patient outcomes considered were applicable patient safety indicators (PSIs), intensive care unit transfers, cardiopulmonary resuscitation/rapid response team calls, and patient deaths. Mixed linear models and generalized linear regression models were used for statistical analysis.RESULTSWorkload measures of midnight census and daily discharges were associated with lower teaching evaluation scores (both β = −0.026, P < 0.0001). The number of daily admissions was associated with higher teaching scores (β = 0.021, P = 0.001) and increased PSIs (odds ratio = 1.81, P = 0.0001).CONCLUSIONSeveral measures of attending physician workload were associated with slightly lower teaching effectiveness, and patient safety may be compromised when teams are managing new admissions. Ongoing efforts by residency programs to optimize the learning environment should include strategies to manage the workload of supervising attendings. Journal of Hospital Medicine 2016;11:169–173. © 2016 Society of Hospital Medicine
The cerebellar channelopathy of multiple sclerosis
Waxman, Stephen G. , Kantarci, Orhun H.

Neurology | January 7, 2016 | Volume: 86 | Issue: 5 | Pages: 406-407

10.1212/wnl.0000000000002338 | PMID 26740676 Get It

Impact of demographics on human gut microbial diversity in a US Midwest population
Ryu, Euijung , Hathcock, Matthew , Nelson, Heidi , Ballman, Karla, Chia, Nicholas , Chen, Jun , Ballman, Karla V. , Chia, Nicholas , Olson, Janet E.

PeerJ | January 7, 2016 | Volume: 4 | Issue: No issue available | Pages: e1514

10.7717/peerj.1514 | PMID 26839739 Get It

The clinical utility of microbiome biomarkers depends on the reliable and reproducible nature of comparative results. Underappreciation of the variation associated with common demographic, health, and behavioral factors may confound associations of interest and generate false positives. Here, we present the Midwestern Reference Panel (MWRP), a resource for comparative gut microbiome studies conducted in the Midwestern United States. We analyzed the relationships between demographic and health behavior-related factors and the microbiota in this cohort, and estimated their effect sizes. Most variables investigated were associated with the gut microbiota. Specifically, body mass index (BMI), race, sex, and alcohol use were significantly associated with microbial β-diversity (P < 0.05, unweighted UniFrac). BMI, race and alcohol use were also significantly associated with microbial α-diversity (P < 0.05, species richness). Tobacco use showed a trend toward association with the microbiota (P < 0.1, unweighted UniFrac). The effect sizes of the associations, as quantified by adjusted R 2 values based on unweighted UniFrac distances, were small (< 1% for all variables), indicating that these factors explain only a small percentage of overall microbiota variability. Nevertheless, the significant associations between these variables and the gut microbiota suggest that they could still be potential confounders in comparative studies and that controlling for these variables in study design, which is the main objective of the MWRP, is important for increasing reproducibility in comparative microbiome studies.
Spanish‐ and English‐Speaking Pregnant Women's Views on cfDNA and Other Prenatal Screening: Practical and Ethical Reflections
Floyd, Erin , Allyse, Megan , Michie, Marsha , Allyse, Megan A., Allyse, Megan A

Journal of Genetic Counseling | January 7, 2016 | Volume: 25 | Issue: 5 | Pages: 965-977

10.1007/s10897-015-9928-3 | PMID 26739840 Get It

AbstractThe rapid clinical implementation of cell‐free DNA (cfDNA) screening, a non‐invasive method of prenatal genetic screening, has outpaced research on its social and ethical implications. This study is the first to compare the ethical and practical views of Spanish‐ and English‐speaking pregnant women in the United States about cfDNA screening. Semi‐structured interviews were conducted with diverse Spanish‐ and English‐speaking women who had received prenatal care at a large academic medical center. Of the 24 interviewees, ten were Latinas who were interviewed in Spanish; English‐language interviews were conducted with seven non‐Hispanic Asian and seven non‐Hispanic White women. Participants held positive opinions concerning the accuracy of cfDNA screening and often noted that it would enhance preparedness. Participants also expressed concerns about the possibility of inaccurate results and the potentially negative effects of cfDNA screening on the experience of pregnancy. Differences emerged between Spanish and English speakers in their portrayals of their relationships with prenatal health care providers, the extent to which they questioned providers’ advice, their ethical concerns, and their informational needs. We emphasize the importance of customizing prenatal test counseling to the needs of the individual patient, providing educationally appropriate counseling and literature, and mitigating potential language barriers.
Muc1 enhances the β-catenin protective pathway during ischemia-reperfusion injury
Al‐bataineh, Mohammad M. , Kinlough, Carol L., Poland, Paul A., Pastor‐Soler, Núria M. , Sutton, Timothy A. , Bastacky, Sheldon , Gendler, Sandra , Madsen, Cathy S., Singh, Sucha , Monga, Satdarshan P. , Hughey, Rebecca P. , Gendler, Sandra J, Mang, Henry Elmer , Monga, Satdarshan

American Journal of Physiology-Renal Physiology | January 7, 2016 | Volume: 310 | Issue: 6 | Pages: F569-F579

10.1152/ajprenal.00520.2015 | PMID 26739894 Get It

The hypoxia-inducible factor (HIF)-1 and β-catenin protective pathways represent the two most significant cellular responses that are activated in response to acute kidney injury. We previously reported that murine mucin (Muc)1 protects kidney function and morphology in a mouse model of ischemia-reperfusion injury (IRI) by stabilizing HIF-1α, enhancing HIF-1 downstream signaling, and thereby preventing metabolic stress (Pastor-Soler et al. Muc1 is protective during kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 308: F1452–F1462, 2015). We asked if Muc1 regulates the β-catenin protective pathway during IRI as 1) β-catenin nuclear targeting is MUC1 dependent in cultured human cells, 2) β-catenin is found in coimmunoprecipitates with human MUC1 in extracts of both cultured cells and tissues, and 3) MUC1 prevents β-catenin phosphorylation by glycogen synthase kinase (GSK)3β and thereby β-catenin degradation. Using the same mouse model of IRI, we found that levels of active GSK3β were significantly lower in kidneys of control mice compared with Muc1 knockout (KO) mice. Consequently, β-catenin was significantly upregulated at 24 and 72 h of recovery and appeared in the nuclear fraction at 72 h in control mouse kidneys. Both β-catenin induction and nuclear targeting were absent in Muc1 KO mice. We also found downstream induction of β-catenin prosurvival factors (activated Akt, survivin, transcription factor T cell factor 4 (TCF4), and its downstream target cyclin D1) and repression of proapoptotic factors (p53, active Bax, and cleaved caspase-3) in control mouse kidneys that were absent or aberrant in kidneys of Muc1 KO mice. Altogether, the data clearly indicate that Muc1 protection during acute kidney injury proceeds by enhancing both the HIF-1 and β-catenin protective pathways.
Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension
Eirin, Alfonso , Zhu, Xiang-Yang, Textor, Stephen C., Lerman, Lilach O. , Sun, Dong , Chen, Zhi , Sun, Dong , Chen, Zhi , Lerman, Amir , Eirin, Alfonso

American Journal of Hypertension | January 7, 2016 | Volume: 29 | Issue: 7 | Pages: 853-859

10.1093/ajh/hpv222 | PMID 26739189 Get It

Abstract BACKGROUND Revascularization of a stenotic renal artery improves kidney function only in select patients with renovascular hypertension (HT) secondary to atherosclerosis. However, the effects of reversal of renovascular HT (RRHT) on the nonstenotic kidney are unclear. We hypothesized that concurrent hypercholesterolemia (HC) attenuates nonstenotic kidney recovery. METHODS Female domestic pigs were randomized as Normal, renovascular HT, HT+RRHT, HTC (renovascular HT and HC), and HTC+RHT ( n = 7 each). RRHT or sham was performed after 6 weeks of HT. Nonstenotic renal blood flow, glomerular filtration rate, and injurious pathways were studied 4 weeks later. RESULTS Mean arterial pressure increased similarly in HT and HTC and decreased after RRHT. Oxidative stress increased in HT and HTC kidneys, and decreased in HT+RRHT, but remained elevated in HTC+RRHT. Renal interstitial fibrosis, glomerulosclerosis, and tubular injury were all attenuated in HT+RRHT, but not HTC+RRHT. Endothelin-1 signaling and PGF2α isoprostane levels were elevated in both HTC and HTC+RRHT pigs. CONCLUSIONS RRHT reverses nonstenotic kidney injury in experimental renovascular HT, but concurrent HC blunts regression of kidney injury, possibly due to predominant vasoconstrictors and oxidative stress. These findings reinforce the contribution of the nonstenotic kidney and of prevailing cardiovascular risk factors to irreversibility of kidney dysfunction after revascularization.
064 Sirolimus as primary immunosuppression is associated with improved renal function and survival compared with calcineurin inhibitors in stable cardiac transplant recipients
Al-Omari, M.A., Raichlin, Eugenia , Edwards, Brooks S., Rodeheffer, R.J., Pereira, Naveen L. , Clavell, Alfredo L. , Kushwaha, Sudhir S. , Frantz, Robert P.

BCS Abstracts 2010 | January 6, 2016 | Volume: No volume available | Issue: No issue available | Pages: A38.1-A38

10.1136/hrt.2010.195966.12 Get It

063 Assessing treatment burden in chronic heart failure patients
Gallacher, KI, Mair, Frances S , May, Carl , Montori, Víctor M.

BCS Abstracts 2010 | January 6, 2016 | Volume: No volume available | Issue: No issue available | Pages: A37.2-A38

10.1136/hrt.2010.195966.11 Get It

A Case of Severe, Prolonged, Refractory Hypophosphatemia After Zoledronic Acid Administration
Clark, Sarah L. , Nystrom, Erin M.

Journal of Pharmacy Practice | January 6, 2016 | Volume: 29 | Issue: 2 | Pages: 172-176

10.1177/0897190015624050 | PMID 26739479 Get It

Zoledronic acid (ZA) administration has been associated with electrolyte abnormalities, including hypocalcemia, hypomagnesemia, hypokalemia, and hypophosphatemia. We describe a case of severe, refractory hypophosphatemia in a patient who received ZA for hypercalcemia of malignancy (HCM). Little data are available that describe the incidence or degree of severity of hypophosphatemia that can occur following ZA administration. In addition, no formal recommendations exist to guide monitoring for or management of electrolyte derangements in the setting of bisphosphonate use. Our patient required daily, high-dose phosphorus replacement beginning day 4 following ZA administration. The average daily dose of phosphorus, including both intravenous and enteral administration, was highest in the first 2 weeks after ZA, averaging 77 mmol/d days 4 through 15, and does not include sources of phosphorus from the patient’s nutrition support. Despite this high amount of supplementation, which was well beyond what meets normal daily requirements and the amount expected to treat “usual” hypophosphatemia, the patient did not achieve sustained normal serum phosphorus levels for over 30 days after ZA. ZA is a favorable option for treating HCM because of its longer duration of action, potent serum calcium-lowering effects, and favorable safety profile. The risk of hypophosphatemia with ZA use is reviewed.
Phase Aberration and Attenuation Effects on Acoustic Radiation Force-Based Shear Wave Generation
Amador, Carolina , Aristizabal, Sara , Greenleaf, James F. , Urban, Matthew W.

IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control | January 6, 2016 | Volume: 63 | Issue: 2 | Pages: 222-232

10.1109/tuffc.2016.2515366 | PMID 26742131 Get It